Literature DB >> 10026333

Predicting bone loss following orthotopic liver transplantation.

O M Crosbie1, R Freaney, M J McKenna, M P Curry, J E Hegarty.   

Abstract

BACKGROUND: Hepatic osteodystrophy occurs in the majority of patients with advanced chronic liver disease with the abnormalities in bone metabolism accelerating following orthotopic liver transplantation (OLT). AIMS: To examine changes in bone mineral density (BMD) following OLT and to investigate factors that lead to bone loss.
METHODS: Twelve patients had BMD (at both the lumbar spine (LS) and femoral neck (FN)) and biochemical markers measured preoperatively and for 24 months following OLT.
RESULTS: BMD was low in 75% of patients prior to OLT and decreased significantly from baseline at the LS at three months and the FN at six months. BMD began to increase thereafter at both sites, approaching baseline values at the LS by 12 months. Bone formation markers, osteocalcin and procollagen type I carboxy propeptide, decreased immediately post-OLT, with a concomitant increase seen in the resorption markers pyridinoline and deoxypyridinoline. This resulted in a negative uncoupling index early post-OLT, that rebounded to positive values after six months. There was a significant correlation between the change in the uncoupling index between six and three months which preceded the increase in BMD at 12 months. The decrease in BMD recorded early post-OLT correlated with vitamin D levels at three months.
CONCLUSIONS: Results suggest that increased resorption and inadequate formation are the major contributors to additional bone loss following OLT. Non-invasive biochemical markers precede later changes in BMD in this patient group following OLT and may have a role in investigating and planning intervention strategies to prevent bone loss in future studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026333      PMCID: PMC1727429          DOI: 10.1136/gut.44.3.430

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  The American Association for the Study of Liver Diseases. Postgraduate course & 41st annual meeting. November 3-6, 1990, Chicago, Illinois. Abstracts.

Authors: 
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

Review 2.  Posttransplantation bone disease.

Authors:  I A Katz; S Epstein
Journal:  J Bone Miner Res       Date:  1992-02       Impact factor: 6.741

3.  Bone disease in liver transplant recipients: incidence, timing, and risk factors.

Authors:  M K Porayko; R H Wiesner; J E Hay; R A Krom; E R Dickson; S Beaver; L Schwerman
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.

Authors:  T H Diamond; D Stiel; M Lunzer; D McDowall; R P Eckstein; S Posen
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

Review 5.  Bone disease in liver transplant recipients.

Authors:  J E Hay
Journal:  Gastroenterol Clin North Am       Date:  1993-06       Impact factor: 3.806

Review 6.  Bone disease in cholestatic liver disease.

Authors:  J E Hay
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

7.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.

Authors:  R Eastell; S P Robins; T Colwell; A M Assiri; B L Riggs; R G Russell
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

8.  Bone loss and turnover in patients with liver transplantation.

Authors:  F G Hawkins; M Leon; M B Lopez; M A Valero; L Larrodera; I Garcia-Garcia; C Loinaz; E Moreno Gonzalez
Journal:  Hepatogastroenterology       Date:  1994-04

9.  Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis.

Authors:  R Eastell; E R Dickson; S F Hodgson; R H Wiesner; M K Porayko; H W Wahner; S L Cedel; B L Riggs; R A Krom
Journal:  Hepatology       Date:  1991-08       Impact factor: 17.425

10.  Bone loss after liver transplantation.

Authors:  J A McDonald; C R Dunstan; P Dilworth; K Sherbon; A G Sheil; R A Evans; G W McCaughan
Journal:  Hepatology       Date:  1991-10       Impact factor: 17.425

View more
  6 in total

Review 1.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

2.  Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation.

Authors:  Peter P Reese; Roy D Bloom; Harold I Feldman; Ari Huverserian; Arwin Thomasson; Justine Shults; Takayuki Hamano; Simin Goral; Abraham Shaked; Kimberly Olthoff; Michael R Rickels; Melissa Bleicher; Mary B Leonard
Journal:  Liver Int       Date:  2011-09-09       Impact factor: 5.828

3.  Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.

Authors:  F Atamaz; S Hepguler; M Akyildiz; Z Karasu; M Kilic
Journal:  Osteoporos Int       Date:  2006-03-21       Impact factor: 4.507

Review 4.  Vitamin D status in gastrointestinal and liver disease.

Authors:  Helen M Pappa; Elana Bern; Daniel Kamin; Richard J Grand
Journal:  Curr Opin Gastroenterol       Date:  2008-03       Impact factor: 3.287

5.  Bone mineral density loss in patients with cirrhosis.

Authors:  Ibrahim N Muhsen; Omar AlFreihi; Faisal Abaalkhail; Abdullah AlKhenizan; Mohammed Khan; Abdelmoneim Eldali; Fahad Alsohaibani
Journal:  Saudi J Gastroenterol       Date:  2018 Nov-Dec       Impact factor: 2.485

6.  Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation.

Authors:  Daniel Kaemmerer; Benjamin Schmidt; Gabriele Lehmann; Gunter Wolf; Utz Settmacher; Merten Hommann
Journal:  Transplant Res       Date:  2012-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.